Clinical trials: CHD
Congenital Heart Disease (CHD), Infective Endocarditis (IE)
Electronic Archive of Patients With Congenital Heart Disease and Diagnosis of Infective Endocarditis
The objective of the study is to create an electronic archive in which to census all newly diagnosed or already diagnosed cases of infective endocarditis and congenital heart disease after 01 January 2022 at the IRCCS AOU Bologna…
- Trial name
- IE-CHD (NCT06777615)
- Where
- Italy
- Volunteers
- 30 people
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
Hypercholesterolemia
To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 mg (0653-090)
To Evaluate and Compare the Efficacy and Safety of Ezetimibe Plus Atorvastatin Versus Atorvastatin in Hypercholesterolemic Patients at High Risk for Coronary Heart Disease Not Adequately Controlled on Atorvastatin 40 mg.
- Trial name
- NCT00276484
- Testing
- atorvastatin, ezetimibe
- Volunteers
- 579 people
- Sponsor
- Organon and Co
Hepatitis D, Chronic
A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)
This study evaluated the efficacy and safety of 48-week treatment with pegylated interferon (PEG-IFN) alfa-2a (Pegasys) monotherapy in participants with chronic hepatitis D (CHD).
- Trial name
- NCT02732639
- Testing
- Pegylated Interferon (PEG-IFN) alfa-2a
- Where
- 7 sites in Romania
- Volunteers
- 31 people
- Sponsor
- Hoffmann-La Roche
Congenital Heart Disease (CHD), Univentricular Heart
Fontan Outcomes in Oligemia vs Plethora in Univentricular CHD
This prospective cohort study evaluates differences in clinical outcomes between pulmonary oligemia and pulmonary plethora in patients with cyanotic congenital heart disease and univentricular heart physiology undergoing staged…
- Trial name
- NCT07535203
- Testing
- Fontan Procedure
- Where
- Indonesia
- Volunteers
- 52 people
- Sponsor
- Sisca Natalia Siagian
Congenital Heart Disease, Cardiac Surgery
Exercise Prehabilitation in Congenital Heart Disease
Around 8-12 in every 1000 babies are born with an abnormal heart, known as a congenital heart defect (CHD). Thanks to major advances in medical and surgical care, most babies born with CHD now live into adulthood.
- Trial name
- ACE-CHD (NCT07700459)
- Testing
- Exercise prehabilitation
- Where
- United Kingdom
- Volunteers
- 32 people
- Sponsor
- Liverpool Heart and Chest Hospital NHS Foundation Trust
Frailty
Long-term Effects of WISE Program Improving Frailty Status and Quality of Life for Adolescents With CHD
Most children with congenital heart disease (CHD) are expected to survive until adulthood. In addition to physical limitations, the growing adolescents with CHD are also challenged at the psychosocial domains.
- Trial name
- NCT05533346
- Testing
- with WISE (Walking Instruction based on Self-Efficacy), without WISE (Walking Instruction based on Self-Efficacy)
- Where
- Taiwan
- Sponsor
- National Yang Ming Chiao Tung University
Congenital Heart Disease (CHD)
The Effect of Therapeutic Play on Preoperative Anxiety in Hospitalized Children With Congenital Heart Disease
Congenital Heart Disease (CHD) is the most common congenital malformation in children and the leading cause of death from birth defects in infancy.
- Trial name
- TP-CHD (NCT07643168)
- Testing
- Therapeutic Play Intervention, Routine Preoperative Nursing
- Volunteers
- 204 people
- Sponsor
- First Affiliated Hospital of Kunming Medical University